Pharmacy

Editor's Choice

Healthcare Reform: Drug Topics readers speak out

With the subject of healthcare reform on the front burner in Washington and across the country, Drug Topics invited members of its Frontline editorial advisory board to share their thoughts. A selection of their responses is presented here.

LATEST ARTICLES

Healthcare Reform: Drug Topics readers speak out

Practical management of asthma (CE)

More than 22 million patients in the United States are affected by asthma and collectively were admitted for approximately 444,000 hospitalizations in 2006. With appropriate assessment and treatment by patients and healthcare providers, hospitalizations and deaths from asthma exacerbations can be significantly reduced. This article reviews the role of available asthma medications and provides an overview of the NAEPP's recommendations for management of asthma for patients 12 years of age and older.

Development of an adverse drug reaction bulletin in a teaching hospital

Bulletins that focus on drugs and therapeutic matters are often distributed by hospitals and other health systems that have programs for reporting adverse drug reactions.

Travoprost: A prostaglandin analogue for the treatment of glaucoma

In August 2003, the US Department of Veterans Affairs (VA) awarded a contract for prostaglandin ophthalmic agents with travoprost as the agent of choice. Although there was no national mandate to switch patients from existing therapy, many VA facilities had agreements from their local ophthalmology and optometry departments to conduct a therapeutic interchange of patients from existing prostaglandins (eg, latanoprost) to travoprost.

Focus on 2009: A year of novel pharmacologic agents in review

This article reviews the 10 newly improved or investigational agents evaluated in this year's "Focus on" column and includes an update on the regulatory status of each drug.